aluates Reports

$ 5800.0

Automative

Global Immunohistochemistry (IHC) Testing Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-24L5599

Global Immunohistochemistry IHC Testing Market Insights Forecast to 2028

BUY CHAPTERS

Global Immunohistochemistry (IHC) Testing Market Research Report 2025

Code: QYRE-Auto-24L5599

Report

July 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Mayo Clinic

Johns Hopkins Hospital

Cleveland Clinic

Dana-Farber/Brigham and Women's Cancer Center

Cedars-Sinai Medical Center

Northwestern Memorial Hospital

Seattle Cancer Care Alliance/University of Washington Medical Center

University of California San Francisco Medical Center

CancerResearchUK

Pfizer Inc

Immunohistochemistry (IHC) Testing Market

The global market for Immunohistochemistry (IHC) Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Immunohistochemistry (IHC) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Immunohistochemistry (IHC) Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Immunohistochemistry (IHC) Testing in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Immunohistochemistry (IHC) Testing include University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Dana-Farber/Brigham and Women's Cancer Center, Cedars-Sinai Medical Center, Northwestern Memorial Hospital, Seattle Cancer Care Alliance/University of Washington Medical Center, University of California San Francisco Medical Center, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immunohistochemistry (IHC) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunohistochemistry (IHC) Testing.

The Immunohistochemistry (IHC) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immunohistochemistry (IHC) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunohistochemistry (IHC) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immunohistochemistry (IHC) Testing Market Report

Report Metric	Details
Report Name	Immunohistochemistry (IHC) Testing Market
Segment by Type	Traditional Direct Method New Direct Method Enzyme Bridgemethod PAP Method
Segment by Application	Hospital Research Institute Corporation Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Dana-Farber/Brigham and Women's Cancer Center, Cedars-Sinai Medical Center, Northwestern Memorial Hospital, Seattle Cancer Care Alliance/University of Washington Medical Center, University of California San Francisco Medical Center, CancerResearchUK, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunohistochemistry (IHC) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immunohistochemistry (IHC) Testing Market report?

Ans: The main players in the Immunohistochemistry (IHC) Testing Market are University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Dana-Farber/Brigham and Women's Cancer Center, Cedars-Sinai Medical Center, Northwestern Memorial Hospital, Seattle Cancer Care Alliance/University of Washington Medical Center, University of California San Francisco Medical Center, CancerResearchUK, Pfizer

What are the Application segmentation covered in the Immunohistochemistry (IHC) Testing Market report?

Ans: The Applications covered in the Immunohistochemistry (IHC) Testing Market report are Hospital, Research Institute, Corporation, Other

What are the Type segmentation covered in the Immunohistochemistry (IHC) Testing Market report?

Ans: The Types covered in the Immunohistochemistry (IHC) Testing Market report are Traditional Direct Method, New Direct Method, Enzyme Bridgemethod, PAP Method

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Traditional Direct Method

1.2.3 New Direct Method

1.2.4 Enzyme Bridgemethod

1.2.5 PAP Method

1.3 Market by Application

1.3.1 Global Immunohistochemistry (IHC) Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Research Institute

1.3.4 Corporation

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunohistochemistry (IHC) Testing Market Perspective (2020-2031)

2.2 Global Immunohistochemistry (IHC) Testing Growth Trends by Region

2.2.1 Global Immunohistochemistry (IHC) Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Immunohistochemistry (IHC) Testing Historic Market Size by Region (2020-2025)

2.2.3 Immunohistochemistry (IHC) Testing Forecasted Market Size by Region (2026-2031)

2.3 Immunohistochemistry (IHC) Testing Market Dynamics

2.3.1 Immunohistochemistry (IHC) Testing Industry Trends

2.3.2 Immunohistochemistry (IHC) Testing Market Drivers

2.3.3 Immunohistochemistry (IHC) Testing Market Challenges

2.3.4 Immunohistochemistry (IHC) Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue

3.1.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue (2020-2025)

3.1.2 Global Immunohistochemistry (IHC) Testing Revenue Market Share by Players (2020-2025)

3.2 Global Immunohistochemistry (IHC) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immunohistochemistry (IHC) Testing Revenue

3.4 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio

3.4.1 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunohistochemistry (IHC) Testing Revenue in 2024

3.5 Global Key Players of Immunohistochemistry (IHC) Testing Head office and Area Served

3.6 Global Key Players of Immunohistochemistry (IHC) Testing, Product and Application

3.7 Global Key Players of Immunohistochemistry (IHC) Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunohistochemistry (IHC) Testing Breakdown Data by Type

4.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Type (2020-2025)

4.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2026-2031)

5 Immunohistochemistry (IHC) Testing Breakdown Data by Application

5.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Application (2020-2025)

5.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Immunohistochemistry (IHC) Testing Market Size (2020-2031)

6.2 North America Immunohistochemistry (IHC) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025)

6.4 North America Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunohistochemistry (IHC) Testing Market Size (2020-2031)

7.2 Europe Immunohistochemistry (IHC) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025)

7.4 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size (2020-2031)

8.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immunohistochemistry (IHC) Testing Market Size (2020-2031)

9.2 Latin America Immunohistochemistry (IHC) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025)

9.4 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size (2020-2031)

10.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 University of Texas MD Anderson Cancer Center

11.1.1 University of Texas MD Anderson Cancer Center Company Details

11.1.2 University of Texas MD Anderson Cancer Center Business Overview

11.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Introduction

11.1.4 University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.1.5 University of Texas MD Anderson Cancer Center Recent Development

11.2 Memorial Sloan Kettering Cancer Center

11.2.1 Memorial Sloan Kettering Cancer Center Company Details

11.2.2 Memorial Sloan Kettering Cancer Center Business Overview

11.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Introduction

11.2.4 Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.2.5 Memorial Sloan Kettering Cancer Center Recent Development

11.3 Mayo Clinic

11.3.1 Mayo Clinic Company Details

11.3.2 Mayo Clinic Business Overview

11.3.3 Mayo Clinic Immunohistochemistry (IHC) Testing Introduction

11.3.4 Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.3.5 Mayo Clinic Recent Development

11.4 Johns Hopkins Hospital

11.4.1 Johns Hopkins Hospital Company Details

11.4.2 Johns Hopkins Hospital Business Overview

11.4.3 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Introduction

11.4.4 Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.4.5 Johns Hopkins Hospital Recent Development

11.5 Cleveland Clinic

11.5.1 Cleveland Clinic Company Details

11.5.2 Cleveland Clinic Business Overview

11.5.3 Cleveland Clinic Immunohistochemistry (IHC) Testing Introduction

11.5.4 Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.5.5 Cleveland Clinic Recent Development

11.6 Dana-Farber/Brigham and Women's Cancer Center

11.6.1 Dana-Farber/Brigham and Women's Cancer Center Company Details

11.6.2 Dana-Farber/Brigham and Women's Cancer Center Business Overview

11.6.3 Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Introduction

11.6.4 Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.6.5 Dana-Farber/Brigham and Women's Cancer Center Recent Development

11.7 Cedars-Sinai Medical Center

11.7.1 Cedars-Sinai Medical Center Company Details

11.7.2 Cedars-Sinai Medical Center Business Overview

11.7.3 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Introduction

11.7.4 Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.7.5 Cedars-Sinai Medical Center Recent Development

11.8 Northwestern Memorial Hospital

11.8.1 Northwestern Memorial Hospital Company Details

11.8.2 Northwestern Memorial Hospital Business Overview

11.8.3 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Introduction

11.8.4 Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.8.5 Northwestern Memorial Hospital Recent Development

11.9 Seattle Cancer Care Alliance/University of Washington Medical Center

11.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Company Details

11.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview

11.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Introduction

11.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Development

11.10 University of California San Francisco Medical Center

11.10.1 University of California San Francisco Medical Center Company Details

11.10.2 University of California San Francisco Medical Center Business Overview

11.10.3 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Introduction

11.10.4 University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.10.5 University of California San Francisco Medical Center Recent Development

11.11 CancerResearchUK

11.11.1 CancerResearchUK Company Details

11.11.2 CancerResearchUK Business Overview

11.11.3 CancerResearchUK Immunohistochemistry (IHC) Testing Introduction

11.11.4 CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.11.5 CancerResearchUK Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Immunohistochemistry (IHC) Testing Introduction

11.12.4 Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025)

11.12.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Mayo Clinic

Johns Hopkins Hospital

Cleveland Clinic

Dana-Farber/Brigham and Women's Cancer Center

Cedars-Sinai Medical Center

Northwestern Memorial Hospital

Seattle Cancer Care Alliance/University of Washington Medical Center

University of California San Francisco Medical Center

CancerResearchUK

Pfizer Inc

List of Tables

Table 1. Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Traditional Direct Method

Table 3. Key Players of New Direct Method

Table 4. Key Players of Enzyme Bridgemethod

Table 5. Key Players of PAP Method

Table 6. Global Immunohistochemistry (IHC) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Immunohistochemistry (IHC) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Immunohistochemistry (IHC) Testing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Immunohistochemistry (IHC) Testing Market Share by Region (2020-2025)

Table 10. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Immunohistochemistry (IHC) Testing Market Share by Region (2026-2031)

Table 12. Immunohistochemistry (IHC) Testing Market Trends

Table 13. Immunohistochemistry (IHC) Testing Market Drivers

Table 14. Immunohistochemistry (IHC) Testing Market Challenges

Table 15. Immunohistochemistry (IHC) Testing Market Restraints

Table 16. Global Immunohistochemistry (IHC) Testing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Immunohistochemistry (IHC) Testing Market Share by Players (2020-2025)

Table 18. Global Top Immunohistochemistry (IHC) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2024)

Table 19. Ranking of Global Top Immunohistochemistry (IHC) Testing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Immunohistochemistry (IHC) Testing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Immunohistochemistry (IHC) Testing, Headquarters and Area Served

Table 22. Global Key Players of Immunohistochemistry (IHC) Testing, Product and Application

Table 23. Global Key Players of Immunohistochemistry (IHC) Testing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Immunohistochemistry (IHC) Testing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2020-2025)

Table 27. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2026-2031)

Table 29. Global Immunohistochemistry (IHC) Testing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Application (2020-2025)

Table 31. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Application (2026-2031)

Table 33. North America Immunohistochemistry (IHC) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Immunohistochemistry (IHC) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Immunohistochemistry (IHC) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2026-2031) & (US$ Million)

Table 48. University of Texas MD Anderson Cancer Center Company Details

Table 49. University of Texas MD Anderson Cancer Center Business Overview

Table 50. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product

Table 51. University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 52. University of Texas MD Anderson Cancer Center Recent Development

Table 53. Memorial Sloan Kettering Cancer Center Company Details

Table 54. Memorial Sloan Kettering Cancer Center Business Overview

Table 55. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product

Table 56. Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 57. Memorial Sloan Kettering Cancer Center Recent Development

Table 58. Mayo Clinic Company Details

Table 59. Mayo Clinic Business Overview

Table 60. Mayo Clinic Immunohistochemistry (IHC) Testing Product

Table 61. Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 62. Mayo Clinic Recent Development

Table 63. Johns Hopkins Hospital Company Details

Table 64. Johns Hopkins Hospital Business Overview

Table 65. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product

Table 66. Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 67. Johns Hopkins Hospital Recent Development

Table 68. Cleveland Clinic Company Details

Table 69. Cleveland Clinic Business Overview

Table 70. Cleveland Clinic Immunohistochemistry (IHC) Testing Product

Table 71. Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 72. Cleveland Clinic Recent Development

Table 73. Dana-Farber/Brigham and Women's Cancer Center Company Details

Table 74. Dana-Farber/Brigham and Women's Cancer Center Business Overview

Table 75. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product

Table 76. Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 77. Dana-Farber/Brigham and Women's Cancer Center Recent Development

Table 78. Cedars-Sinai Medical Center Company Details

Table 79. Cedars-Sinai Medical Center Business Overview

Table 80. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product

Table 81. Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 82. Cedars-Sinai Medical Center Recent Development

Table 83. Northwestern Memorial Hospital Company Details

Table 84. Northwestern Memorial Hospital Business Overview

Table 85. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product

Table 86. Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 87. Northwestern Memorial Hospital Recent Development

Table 88. Seattle Cancer Care Alliance/University of Washington Medical Center Company Details

Table 89. Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview

Table 90. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product

Table 91. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 92. Seattle Cancer Care Alliance/University of Washington Medical Center Recent Development

Table 93. University of California San Francisco Medical Center Company Details

Table 94. University of California San Francisco Medical Center Business Overview

Table 95. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product

Table 96. University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 97. University of California San Francisco Medical Center Recent Development

Table 98. CancerResearchUK Company Details

Table 99. CancerResearchUK Business Overview

Table 100. CancerResearchUK Immunohistochemistry (IHC) Testing Product

Table 101. CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 102. CancerResearchUK Recent Development

Table 103. Pfizer Company Details

Table 104. Pfizer Business Overview

Table 105. Pfizer Immunohistochemistry (IHC) Testing Product

Table 106. Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2020-2025) & (US$ Million)

Table 107. Pfizer Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Immunohistochemistry (IHC) Testing Picture

Figure 2. Global Immunohistochemistry (IHC) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immunohistochemistry (IHC) Testing Market Share by Type: 2024 VS 2031

Figure 4. Traditional Direct Method Features

Figure 5. New Direct Method Features

Figure 6. Enzyme Bridgemethod Features

Figure 7. PAP Method Features

Figure 8. Global Immunohistochemistry (IHC) Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Immunohistochemistry (IHC) Testing Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Research Institute Case Studies

Figure 12. Corporation Case Studies

Figure 13. Other Case Studies

Figure 14. Immunohistochemistry (IHC) Testing Report Years Considered

Figure 15. Global Immunohistochemistry (IHC) Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Immunohistochemistry (IHC) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Immunohistochemistry (IHC) Testing Market Share by Region: 2024 VS 2031

Figure 18. Global Immunohistochemistry (IHC) Testing Market Share by Players in 2024

Figure 19. Global Top Immunohistochemistry (IHC) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Immunohistochemistry (IHC) Testing Revenue in 2024

Figure 21. North America Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Immunohistochemistry (IHC) Testing Market Share by Country (2020-2031)

Figure 23. United States Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Immunohistochemistry (IHC) Testing Market Share by Country (2020-2031)

Figure 27. Germany Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Region (2020-2031)

Figure 35. China Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Immunohistochemistry (IHC) Testing Market Share by Country (2020-2031)

Figure 43. Mexico Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Country (2020-2031)

Figure 47. Turkey Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Immunohistochemistry (IHC) Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. University of Texas MD Anderson Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 51. Memorial Sloan Kettering Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 52. Mayo Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 53. Johns Hopkins Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 54. Cleveland Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 55. Dana-Farber/Brigham and Women's Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 56. Cedars-Sinai Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 57. Northwestern Memorial Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 58. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 59. University of California San Francisco Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 60. CancerResearchUK Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 61. Pfizer Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.